Monthly Round-Up of What to Read on Pharma Law and Policy
Topics range from issues related to FDA’s approval of aducanumab, to an analysis of the communication of survival data in cancer drug labels.
Professional Regulation
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy -
Read more: The Biden Administration Should Resolve Cannabis Regulation Chaos The Biden Administration Should Resolve Cannabis Regulation Chaos
The Biden Administration has the opportunity to be the first administration to rid our legal system of cannabis regulation chaos.
-
Read more: To Address the Overdose Epidemic, Tackle Pharma Industry Influence To Address the Overdose Epidemic, Tackle Pharma Industry Influence
To combat the opioid epidemic, we have to understand how regulators failed to protect the public health as the market for prescription opioids grew.
-
Read more: Research and Regulation of Less-Lethal Projectiles Critically Needed Research and Regulation of Less-Lethal Projectiles Critically Needed
To protect human rights and civil liberties, we must better understand and regulate projectiles, which are dangerous and poorly studied weapons.
-
Read more: Expanding The Right to Try Unproven Treatments: A Dangerous, Deregulatory Proposal Expanding The Right to Try Unproven Treatments: A Dangerous, Deregulatory Proposal
As has been proven time and again, “gut feeling” and wishful thinking have never been shown to replace controlled clinical testing.
-
Read more: Long-Term Care After COVID: A Roadmap for Law Reform Long-Term Care After COVID: A Roadmap for Law Reform
There are a series of practical reforms that could readily improve the quality of nursing home care.
-
Read more: Fixing Prices: Immigration and Physician Competition Fixing Prices: Immigration and Physician Competition
There are many highly-trained physicians in the world who would be happy to work in the U.S. Why not let them in and introduce some free-market competition?
-
Read more: Price Transparency: Progress, But Not Yet Celebration Price Transparency: Progress, But Not Yet Celebration
Price transparency has long eluded the health care industry, but change — fueled by rare bipartisan support — is afoot.
-
Read more: Be a Transformational President, Mr. Biden: Launch a Commission to Create an Ethical Health Care System Be a Transformational President, Mr. Biden: Launch a Commission to Create an Ethical Health Care System
My message for President Joe Biden and his administration is a simple one. Invite physicians to create an ethical health care system.
-
Read more: When Will the NHS Get Its Complaints System Right? When Will the NHS Get Its Complaints System Right?
The NHS has been trying to get an effective, fit-for-purpose complaints system for at least 28 years, and it has still not succeeded.
